Neovasc Inc. Operating Cash Flow Margin

Operating Cash Flow Margin of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Cash Flow Margin growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Cash Flow Margin for the quarter ending March 31, 2022 was -1143.15% (a 88.34% increase compared to previous quarter)
  • Year-over-year quarterly Operating Cash Flow Margin increased by 4.34%
  • Annual Operating Cash Flow Margin for 2021 was -1084.57% (a -30.13% decrease from previous year)
  • Annual Operating Cash Flow Margin for 2020 was -1552.21% (a 35.46% increase from previous year)
  • Annual Operating Cash Flow Margin for 2019 was -1145.88% (a -12.07% decrease from previous year)
  • Twelve month Operating Cash Flow Margin ending March 31, 2022 was -958.84% (a -11.72% decrease compared to previous quarter)
  • Twelve month trailing Operating Cash Flow Margin decreased by -32.16% year-over-year
Trailing Operating Cash Flow Margin for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
-958.84% -1086.15% -1303.77% -1413.29%
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Cash Flow Margin of Neovasc Inc.

Most recent Operating Cash Flow Marginof NVCN including historical data for past 10 years.

Interactive Chart of Operating Cash Flow Margin of Neovasc Inc.

Neovasc Inc. Operating Cash Flow Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -1143.15%
2021 -606.96% -1054.65% -1095.59% -1916.82% -1084.57%
2020 -1353.12% -1416.91% -2481.27% -1289.36% -1552.21%
2019 -1039.73% -1351.13% -1150.28% -1069.78% -1145.88%
2018 -1141.13% -1136.96% -1508.79% -1543.22% -1303.22%
2017 -10131.24% -293.93% -298.27% -425.87% -2572.16%
2016 -243.49% -366.43% -645.86% -543.36% -418.32%
2015 -277.88% -260.08% -177.52% -150.05% -214.33%
2014 -101.31% -90.19% -31.79% -20.1% -56.11%
2013 -33.57% -42.31% -40.66% -43.61% -39.79%
2012 -14.19% -23.33% -37.68% -35.09% -25.96%
2011 -111.54% -38.29%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.